Earnings Call · Q2 FY2025·2025-08-07

Q2 25EPS +29.41%·Rev n/aQ1 25EPS -7.14%·Rev n/aQ4 24EPS +18.42%·Rev n/aQ3 24EPS -30.77%·Rev n/a⚠ consensus missing

AbCellera Biologics Inc. ABCL

Tryn T. Stimart — Chief Legal and Compliance Officer

Carl L.G. Hansen — President and CEO

Andrew Booth — Chief Financial Officer

+2.9%1d on move date+3.0% vs SPY3d+9.2%5d+11.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABCL calls or request research access.

More ABCL calls Browse calls Request research access